August 9, 2021

How to achieve scalable freezing & thawing of biopharmaceuticals

Reading time: < 1 minutes

“Scalability” is and will remain an important topic in Biopharma.
No matter what area of application it will be necessary to scale-up or down at some point. Scaling-up from doing research in small lab environments with a handful of scientists to commercial production of bulk drug substances, vaccine production or cell and gene therapies entails a number of challenges.

What is scalability?

Scalability around freezing means the ability to guarantee constant stress on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios.

How to enable scalability?

Single Use Support fulfils this requirement by standardizing the IFGS – ice front growth speed – for all possible scenarios regardless of the filling volume and type of bags but also regardless of the type of system, i.e. whether LabScale or LargeScale.

The “Scalability Guide” illustrates how to enable scalable results regardless of the

  • Size of the single-use bags
  • Size of the freezing & thawing platform
  • Number of single use bags you put into the freeze & thaw platforms for a freeze run.

Download Scalability Guide

ice front growth speed for scalability of single use bags in biopharma

Michael Eder

Business Development / Marketing Manager


For any press related inquiries, please reach out to